# Iambic Therapeutics

**Canonical:** https://apis.io/providers/iambic/  
**Website:** https://www.iambic.ai/  
**APIs profiled:** 0

Iambic Therapeutics is a clinical-stage AI drug discovery company headquartered in San Diego. Its proprietary AI platform pairs the NeuralPLexer 3D generative model for protein-ligand structure prediction with the Enchant multimodal transformer for clinical and preclinical endpoint prediction, integrated with automated wet-lab capabilities. Iambic's clinical pipeline includes IAM1363 (HER2), IAM-K1 (KIF18A), and IAM-C1 (CDK2/4) in oncology. Iambic is a therapeutics developer rather than an API provider and does not publish a public developer API or open-source platform.

## Kin Score — 9.8 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 9.8).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 14.3 |
| Commercial Clarity | 7.9 |
| Access Clarity | 7.9 |

Regulatory layer — **Health**: 21.3 (matched via tags).

## Agent readiness — 8.5 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | yes |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Iambic Domain Security** — TLSv1.3 · HSTS · DMARC

## Use cases (3)

- **AI-Driven Small-Molecule Design** — End-to-end design of novel small-molecule therapeutics using generative AI.
- **Protein-Ligand Structure Prediction** — Structural prediction to support hit discovery and lead optimization.
- **Clinical Endpoint Prediction** — Machine-learning prediction of preclinical and clinical endpoints to guide program selection.

## Tags

Drug Discovery, AI for Science, Therapeutics, Biotech, Oncology, Clinical-Stage Pipeline, Generative Chemistry, Structural Biology

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/iambic/). Scores are computed from the provider's own public artifacts under a published rubric.